Extendicare Inc. (TSE:EXE - Get Free Report)'s share price crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of C$10.53 and traded as high as C$13.31. Extendicare shares last traded at C$13.30, with a volume of 261,885 shares.
Analysts Set New Price Targets
Several brokerages recently weighed in on EXE. TD Securities lifted their price objective on shares of Extendicare from C$10.50 to C$13.00 and gave the company a "hold" rating in a research report on Monday, March 3rd. Cormark upgraded Extendicare to a "moderate buy" rating in a research report on Wednesday, February 19th. Finally, BMO Capital Markets raised their target price on Extendicare from C$11.00 to C$13.50 in a research report on Monday, March 3rd.
Check Out Our Latest Report on Extendicare
Extendicare Stock Down 2.6 %
The stock has a market cap of C$1.07 billion, a P/E ratio of 16.27 and a beta of 1.26. The company has a current ratio of 0.62, a quick ratio of 0.98 and a debt-to-equity ratio of 283.02. The stock's 50-day moving average is C$12.09 and its 200-day moving average is C$10.63.
Extendicare Dividend Announcement
The business also recently disclosed a monthly dividend, which was paid on Monday, March 17th. Investors of record on Monday, March 17th were paid a dividend of $0.04 per share. The ex-dividend date was Friday, February 28th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.76%. Extendicare's dividend payout ratio is presently 61.20%.
About Extendicare
(
Get Free Report)
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Stories
Before you consider Extendicare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.
While Extendicare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.